Colombia’s delayed medical cannabis industry could see its first sale within days, according to one of the country’s leading producers.

Khiron Life Sciences announced Friday that it became “the first company” authorized to sell medical cannabis in Colombia.

The Latin American nation’s medical cannabis industry had been expected to launch in 2019, so the announcement is a positive milestone.

For years, government and corporate leaders in Colombia have been touting the potential economic and social benefits of the burgeoning sector.

In Latin America, Colombia has received the lion’s share of foreign direct investments related to cannabis, mostly capital raised in Canada – to the tune of about $400 million as of last September.

However, fresh capital mostly dried up toward the end of 2019 as investors started demanding results after years of promises.